Deep Vein Thrombosis: Diagnosis & Treatment Reginald E. Smith ...

More documents

Recommendations

Info

Pulmonary Embolism Shortness of breath Pleuretic Chest + Rib Pain (worsens with breathing) Bloody sputum Dyspena, Fatigue LA=left atrium; LV=left ventricle; PE=pulmonary embolism; RA=right atrium; RV=right ventricle Figure from Tapson VF. N Engl J Med. 2008;358:1037-1052. Copyright ©2008 Massachusetts Medical Society. All rights reserved. 22 22
Pulmonary Embolism: A Life-threatening Disease Cumulative mortality following acute PE Mortality rate (%; excluding PE first recognised at necropsy) 16 14 12 10 8 6 4 2 0 15.3% Mortality At 3 months International Cooperative Pulmonary Embolism Registry N=2454 0 10 20 30 40 50 60 70 80 90 Time from diagnosis (days) PE=pulmonary embolism Goldhaber SZ et al; for ICOPER. Lancet. 1999;353:1386–1389. 23 2 3 23
Page 1 and 2: Deep Vein Thrombosis: Diagnosis & T
Page 3 and 4: Fail or Win 3
Page 6 and 7: Virchow’s Triad and Thrombus Form
Page 8 and 9: Pathophysiology of DVT Most Often
Page 11 and 12: Late Presentation Is Common The Ris
Page 13 and 14: WELLS Scale For Pretest Probability
Page 15 and 16: Sensitivity & Specificity Of D-Dime
Page 17 and 18: Compression Ultrasound Lower Extrem
Page 19 and 20: Deep Vein Clots Are Big Measured In
Page 21: Pulmonary Embolism 21
Page 25 and 26: Diagnostic Testing for PE CT Angiog
Page 27 and 28: Acute Pulmonary Embolism R Axis Dev
Page 29: Grade IA Symptomatic Proximal DVT G
Page 32 and 33: Therapy: Do We Need To Anticoagulat
Page 34 and 35: Overlapping Heparins, LMWH or Fonda
Page 36 and 37: Does SYMPTOMATIC Calf DVT Require T
Page 38 and 39: Cancer Associated Thrombosis 38
Page 40 and 41: Treatment Of Cancer Associated Thro
Page 42 and 43: Novel Anticoagulants: The Future of
Page 44 and 45: New Oral Anticoagulant Agents In De
Page 46 and 47: Dabigatran etexilate: a novel direc
Page 48 and 49: RE-LY ® - study design Atrial fibr
Page 50 and 51: Major bleeding rates 3.50 3.00 2.50
Page 52 and 53: Most common adverse events Dabigatr
Page 54 and 55: RE-COVER TM Trial Design Singledumm
Page 56 and 57: Cumulative risk of first event of m
Page 58 and 59: Dabigatran: How To Measure Effect?
Page 60: Bleeding Management Withhold Dabiga
Page 63 and 64: Rivaroxaban Brand name Xarelto ® ,
Page 65 and 66: Effect of Rivaroxaban On Coagulatio

Deep Vein Thrombosis: Diagnosis & Treatment Reginald E. Smith ...

Create successful ePaper yourself

Delete template?

Save as template?